Sanofi (SNYNF) Stock Price, News & Analysis

Company Overview

Sanofi is a France-based global healthcare company focused on the research, development, manufacturing and commercialization of pharmaceutical products and vaccines. Its portfolio includes medicines for immunology, rare diseases, neurology, oncology and other specialty-care areas, as well as treatments for common conditions such as diabetes and cardiovascular disease.

The company’s well-known products include Dupixent, an immunology medicine developed with Regeneron; vaccines marketed through its Vaccines division, including influenza and travel vaccines; and established prescription medicines in several therapeutic categories. Sanofi also develops biologic medicines and other innovative therapies for patients with chronic, debilitating or rare conditions.

Sanofi serves patients and healthcare providers in markets around the world through research, manufacturing and commercial operations across North America, Europe, Asia and other international regions. The company was created in its current form through the 2004 merger of Sanofi-Synthélabo and Aventis, combining the businesses of two major French pharmaceutical groups. Its global headquarters are in Paris, France, and Paul Hudson has served as chief executive officer since 2019.

Key Stats

• Today's Range: $94.30 to $96.57
• 50-Day Range: $76.76 to $96.26
• 52-Week Range: $76.76 to $106.34
• Volume: 2,988 shs
• Average Volume: 24,982 shs
• Market Capitalization: N/A
• P/E Ratio: 31.21
• Dividend Yield: 2.91%
• Price Target: N/A
• Consensus Rating: N/A

Sanofi Stock Analysis - MarketRank™

Sanofi scored higher than 13% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Sanofi.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Sanofi is 31.21, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 26.56.

Price to Earnings Ratio vs. Sector

The P/E ratio of Sanofi is 31.21, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 35.15.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Sanofi has a short interest ratio ("days to cover") of 42.73, which indicates bearish sentiment.

Change versus previous month

Short interest in Sanofi has recently decreased by 20.90%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Leadership

Sanofi is a leading dividend payer. It pays a dividend yield of 4.13%, putting its dividend yield in the top 25% of dividend-paying stocks.

Dividend Growth

Sanofi does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Sanofi is 90.78%. Payout ratios above 75% are not desirable because they may not be sustainable.

News and Social Media

• Score: 1.1 / 5
• News Sentiment: -0.20

News Sentiment

Sanofi has a news sentiment score of -0.20. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.38 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 3 news articles for Sanofi this week, compared to 1 article on an average week.

Company Ownership

• Score: 0.4 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Sanofi insiders have not sold or bought any company stock.

Percentage Held by Institutions

30.06% of the stock of Sanofi is held by institutions.

Company Calendar

• Today: 11/09/2026
• Next Earnings (Estimated): 1/28/2027

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: OTCMKTS:SNYNF
• CIK: 1121404
• Web: www.sanofi.com
• Phone: (315) 377-4000
• Fax: N/A
• Employees: 76,493
• Year Founded: 2004

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 31.21
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A